Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…tension, obesity/overweight, COPD, MASLD/MASH, liver cirrhosis, hepatocellular carcinoma, cardiovascular disease, chronic kidney disease, non-liver canc…
…Background Hepatocellular carcinoma (HCC) remains a major cause of cancer-related mortality worldwi…
…ne checkpoint inhibitors (ICIs) demonstrate limited efficacy in hepatocellular carcinoma (HCC), largely attributable to a profoundly immunosuppressive t…
…tudies and case series raised concerns about decreased rates of de novo HCC following DAA therapy, particularly in patients with advanced c…
…Background Hepatocellular carcinoma (HCC) patients are often diagnosed with advanced-stage disease.…
…Background Metabolic reprogramming is a hallmark of hepatocellular carcinoma (HCC), enabling rapid tumour growth and immune evasion. Protein…
…Aims Multifocal hepatocellular carcinoma (HCC) is traditionally classified as multicentric occurrence (M…
…revealed distinct systemic immune states by etiology: non-viral HCC exhibited CD8 + T cells with heightened cytotoxic and memory-as…
…in HCC.Methods Syngeneic orthotopic and intrahepatic metastatic HCC mouse models were used to evaluate the effects of liver-directe…
…arded as a more feasible clinical endpoint for the treatment of chronic hepatitis B (CHB).1 In a recent study by Tseng et al, which explored the associat…
… metastasis model. Ex vivo studies using freshly resected human HCC and liver metastasis tissues further validated immune modulator…
…ent of immunosuppressive CD14 CTX was observed in patients with HCC and CPB but not CPA liver disease, indicating a potential mecha…